Navigation Links
Cardiome Announces Management Transition
Date:8/3/2009

Mr. Janzen, 40, joined Cardiome as Chief Financial Officer in January 2003, and was appointed President and Chief Business Officer in March 2006, at which time he joined the Board of Directors of Cardiome.

About Cardiome Pharma Corp.

Cardiome Pharma Corp. is a product-focused drug development company dedicated to the advancement and commercialization of novel treatments for disorders of the heart and circulatory system. Cardiome is traded on the NASDAQ National Market (CRME) and the Toronto Stock Exchange (COM). For more information, please visit our web site at www.cardiome.com.

Forward-Looking Statement Disclaimer

Certain statements in this press release contain forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995 or forward-looking information under applicable Canadian securities legislation that may not be based on historical fact, including without limitation statements containing the words "believe", "may", "plan", "will", "estimate", "continue", "anticipate", "intend", "expect" and similar expressions. Such forward-looking statements or information involve known and unknown risks, uncertainties and other factors that may cause our actual results, events or developments, or industry results, to be materially different from any future results, events or developments expressed or implied by such forward-looking statements or information. Such factors include, among others, our stage of development, lack of product revenues, additional capital requirements, risk associated with the completion of clinical trials and obtaining regulatory approval to market our products, the ability to protect our intellectual property, dependence on collaborative partners and the prospects for negotiating additional corporate collaborations or licensing arrangements and their timing. Specifically, certain risks and
'/>"/>

SOURCE Cardiome Pharma Corp.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine news :

1. Cardiome Achieves Milestone From Collaboration With Merck Co., Inc.
2. Cardiome Announces That Collaboration and License Agreement with Merck & Co., Inc. Now Effective
3. Cardiome Reports First Quarter Results
4. Cardiome to Hold Conference Call
5. CardioCareLive.com, First Ever Online Cardiometabolic Conference, Revolutionizes Continuing Medical Education for Cardiovascular Healthcare Professionals
6. Cardiome Reports 2008 Results
7. CardioCareLive, First-Ever Online Cardiometabolic Conference, Debuts Today
8. Noninvasive Medical Technologies to Exhibit at CardioCareLive - A Premier Cardiometabolic Conference
9. Cardiome Discloses Chairman And CEOs Involuntary Share Sale
10. Cardiome Provides Regulatory Update
11. Cardiome To Release Second Quarter Results And Hold Conference Call
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/25/2014)... -- Among early stage breast cancer patients who undergo ... percent will eventually develop leukemia as a result of ... comes from a review of more than 20,000 breast ... suggests that the risk for developing treatment-related leukemia, though ... "The frequency of bone marrow cancers such as ...
(Date:12/25/2014)... “ SmileStix ” was featured on NewsWatch as ... coolest mobile applications on the iOS, Android, and Windows markets. ... conducted the app review and shared with viewers how this ... The old saying goes, “A picture says a thousand words.” ... describe a single image, because each picture holds a unique ...
(Date:12/25/2014)... December 25, 2014 Parker & Sons, ... customer service and affordable quality regarding heating, cooling and ... recognition in 2014 by the “Queen of Clean” for ... earned an impressive reputation over the years for providing ... wide range of contractor services for both homeowners and ...
(Date:12/24/2014)... Connie Casad, MD, a well-known and respected ... 30 years of practice experience in Dallas, Texas, has ... of dietary detoxification. The second study is scheduled to ... from test patients who just completed a 21-day detoxification ... in conducting the study, Dr. Casad said, "About 10 ...
(Date:12/24/2014)... TX (PRWEB) December 24, 2014 Dr. ... announced the expansion of his practice and med-spa with ... the practice’s growing list of cosmetic treatments and services. ... solution into the skin,” says Dr. Ho. “As a ... changes such as wrinkles, sun spots, discolorations or blemishes.” ...
Breaking Medicine News(10 mins):Health News:Breast Cancer Chemo Tied to Small But Significant Leukemia Risk 2Health News:Breast Cancer Chemo Tied to Small But Significant Leukemia Risk 3Health News:An Application to Create Custom Stickers was Featured on NewsWatch Television on December 19, 2014 2Health News:Parker & Sons Announces Recognition In 2014 By The “Queen Of Clean” For Impressive Contractor Services In Arizona 2Health News:Parker & Sons Announces Recognition In 2014 By The “Queen Of Clean” For Impressive Contractor Services In Arizona 3Health News:Connie Casad, MD, Now Accepting Test Participants for January Dietary Detoxification Study 2Health News:Connie Casad, MD, Now Accepting Test Participants for January Dietary Detoxification Study 3Health News:Dr. Vu Ho Expands Facial Plastic Surgery Practice to Include New Skin Care Treatment 2
... treatment in adults as well as children , , MONDAY, ... off-label use of anticancer drugs in adults and children ... of that off-label use was for palliative care, say ... countries. , In off-label use, a drug is used ...
... DALLAS, Oct. 27 From Illinois to California, ... (Connecting About,Real Experiences) to find out about patients, ... visit. Hospitals participating in the initial,launch of this ... IL;,Clovis Community Medical Center in Clovis, CA; HealthONE ...
... 27 Accuray,Incorporated (Nasdaq: ARAY ), a global ... management is scheduled to present at the 19th,Annual Oppenheimer ... at 10:00 a.m. EST (7:00 a.m. PST.), A ... from the,investor relations page of the Company,s Web site ...
... New, dual action iron supplement pill with virtually no ... and nutritional benefits from ... iron to be available without prescription, CHICAGO, Oct. ... (http://www.alavenpharm.com ), an over-the-counter,iron supplement that offers both ...
... 5-Aminosalicylates Will Continue to be Used in ... Report from Decision Resources, WALTHAM, Mass., ... the,world,s leading research and advisory firms focusing ... Tanabe,s,Remicade is currently the leading biologic for ...
... to be presented Saturday, November 1, 2008 at this ... Francisco, California, October 31-November 4, SAN FRANCISCO, Oct. ... for a liver transplantation and 22,863 adults,who received transplantation ... that the increase in posttransplant,mortality caused by differences in ...
Cached Medicine News:Health News:Most Off-Label Cancer Drug Use for Palliative Care 2Health News:The Beryl Companies Launches CARE Calls Program in Five Hospitals Across U.S. 2Health News:Accuray Incorporated to Speak at Oppenheimer Healthcare Conference 2Health News:First-Ever Over-the-Counter Dual Action Iron Supplement Launched at the American Dietetic Association Conference in Chicago; Bifera to be Available in Select Stores in Early 2009 2Health News:Humira to Replace Remicade as First Choice Among Biologics for the Treatment of Crohn's Disease 2Health News:Humira to Replace Remicade as First Choice Among Biologics for the Treatment of Crohn's Disease 3Health News:Early Liver Transplantation Regardless of Donor Type Increases Long-term Survival 2
(Date:12/24/2014)... N.C. , Dec. 23, 2014  Medical Science ... As the key link between the medical device industry ... even more in the coming years as the device ... According to research by benchmarking firm, Best ... can gain an important edge is by harnessing new ...
(Date:12/22/2014)... 22, 2014 Research and Markets ( ... "US Self-monitoring Blood Glucose Market" report to their ... This market insight focuses on the developments in ... United States . Reimbursement analysis and the effects ... for more than 73 SMBG meters have been performed, ...
(Date:12/22/2014)... Cyberonics, Inc. (NASDAQ: CYBX ), a global leader ... today announced it will participate in the 33 rd ... in San Francisco . ... speak at 11:00 AM Pacific Time.  A live audio webcast ... Investor Relations link on the Cyberonics home page at ...
Breaking Medicine Technology:Role of Medical Science Liaisons Evolving in Medical Device Sector 2US Self-monitoring Blood Glucose Market 2
... BioStorage Technologies, Inc., a worldwide provider of long- ... chain logistics, will expand its European operations with the ... meters) full-service biorepository in Frankfurt, Germany. , BioStorage Technologies, ... growth plan to accommodate a rapidly growing list of ...
... PRINCETON, N.J., Oct. 21 PharmaNet Development Group, Inc., ... biotechnology, generic drug and medical device companies, today announced ... Trials Conference taking place at the World Trade Center ... , At the conference, top management will discuss ...
Cached Medicine Technology:BioStorage Technologies, Inc., Accelerates European Expansion with Opening of New German Facility 2PharmaNet Development Group Management Participates in the 8th Annual Partnerships in Clinical Trials Conference in Rotterdam 2
The care package includes a spare motor, fuse, Spare Fluorescent Bulb, additional Vibratome Feather Blades, Specimen Adhesive, Specimen Mounting Blocks, and a Specimen Tray....
... (10 to 12) brain slices to be ... maintaining excellent viability. A mixture of 95% ... This initiates a circular flow and oxygen ... Slices remain viable for hours while awaiting ...
... provides a convenient reservoir of cooling water for the ... extended period of time or in a location which ... the hot side of the thermoelectric heat pump. ... is adequate to run the 900R for up to ...
Punch set for Advanced Tissue Arrayer, 0.6 mm...
Medicine Products: